Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Mills

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society|September 1, 1993
Thrombotic thrombocytopenic purpuraG M Mills, B A Baethge, W N Ball, et al.
Cancer Drug Delivery|January 1, 1984
Predictive value of trypan blue exclusion viability measurements for colony formation in a human tumor cloning assayJ D Cowan, D D Von Hoff, B Neuenfeldt, et al.
European Journal of Gynaecological Oncology|November 7, 2001
Cauda equina compression in breast cancer--incidence and treatment outcomeF L Ampil, G V Burton, G M Mills, et al.
Oncogene|August 5, 2014
Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defectsE Martínez, K Yoshihara, H Kim, et al.
American Journal of Otolaryngology|February 15, 2001
Radical combined treatment of locally extensive head and neck cancer in the elderlyF L Ampil, G M Mills, F J Stucker, et al.
JAMA|December 9, 1983
Ineffective epoprostenol therapy for thrombotic thrombocytopenic purpuraJ E Johnson, G M Mills, A G Batson, et al.
Acta Haematologica|January 1, 1990
Antinuclear antibodies in sickle cell diseaseB A Baethge, T R Bordelon, G M Mills, et al.
American Journal of Clinical Oncology|December 1, 1989
Phase II evaluation of bisantrene in acute leukemia. A Southwest Oncology Group StudyG M Mills, S Dahlberg, J Cowan, et al.
Investigational New Drugs|September 20, 2001
Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II studyW E Samlowski, H Gundacker, J P Kuebler, et al.
The Prostate|March 10, 2001
A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407)K J Pienta, E I Fisher, M A Eisenberger, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Journal of the Louisiana State Medical Society : Official Organ of the Louisiana State Medical Society|September 1, 1993
Thrombotic thrombocytopenic purpuraG M Mills, B A Baethge, W N Ball, et al.
Cancer Drug Delivery|January 1, 1984
Predictive value of trypan blue exclusion viability measurements for colony formation in a human tumor cloning assayJ D Cowan, D D Von Hoff, B Neuenfeldt, et al.
European Journal of Gynaecological Oncology|November 7, 2001
Cauda equina compression in breast cancer--incidence and treatment outcomeF L Ampil, G V Burton, G M Mills, et al.
Oncogene|August 5, 2014
Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defectsE Martínez, K Yoshihara, H Kim, et al.
American Journal of Otolaryngology|February 15, 2001
Radical combined treatment of locally extensive head and neck cancer in the elderlyF L Ampil, G M Mills, F J Stucker, et al.
JAMA|December 9, 1983
Ineffective epoprostenol therapy for thrombotic thrombocytopenic purpuraJ E Johnson, G M Mills, A G Batson, et al.
Acta Haematologica|January 1, 1990
Antinuclear antibodies in sickle cell diseaseB A Baethge, T R Bordelon, G M Mills, et al.
American Journal of Clinical Oncology|December 1, 1989
Phase II evaluation of bisantrene in acute leukemia. A Southwest Oncology Group StudyG M Mills, S Dahlberg, J Cowan, et al.
Investigational New Drugs|September 20, 2001
Evaluation of gemcitabine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group phase II studyW E Samlowski, H Gundacker, J P Kuebler, et al.
The Prostate|March 10, 2001
A phase II trial of estramustine and etoposide in hormone refractory prostate cancer: A Southwest Oncology Group trial (SWOG 9407)K J Pienta, E I Fisher, M A Eisenberger, et al.
Pageof 4